Plain-English translation of NCT07006571 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a home-based brain stimulation device called transcranial direct current stimulation (tDCS) to see if it can help slow muscle weakness in people with ALS. The device is small and designed to be used safely at home, delivering gentle electrical stimulation to the brain and spinal cord through electrodes placed on the skin. Researchers believe this treatment might help protect nerve cells and improve muscle strength in ALS patients.
ALS is a serious disease that causes progressive muscle weakness, and currently there are very few treatment options available. Early research suggests this type of brain stimulation may help preserve muscle function and slow disease progression, so this trial aims to test whether regular home-based treatment could offer meaningful benefit to ALS patients.
You likely qualify if…
You likely don't qualify if…
You would use the tDCS device at home five days per week (Monday through Friday) for 16 weeks. Each session takes about 20 minutes and involves placing two electrodes on your skin—one on your head and one on your neck—while the device delivers mild electrical stimulation. Your caregiver will help you set up and use the device safely. You may receive the real treatment or a placebo (inactive device), and researchers will monitor your muscle strength and overall function throughout the study.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
Italy